down arrow

Mankind Pharma

26
Strong Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,340.80
10.45 (0.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
Operating Income
10,334.00
8,749.00
7,781.00
6,214.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
10,334.00
8,749.00
7,781.00
6,214.00
Expenditure (Ex Depriciation)
Stock Adjustments
-94.00
289.00
-449.00
-247.00
Raw Materials Consumed
3,263.00
2,622.00
2,871.00
2,028.00
Power & Fuel Cost
129.00
108.00
103.00
82.00
Employee Cost
2,274.00
1,918.00
1,620.00
1,415.00
Operating Expenses
210.00
139.00
114.00
93.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
928.00
638.00
708.00
587.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
134.00
151.00
121.00
106.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
7,798.00
6,847.00
5,791.00
4,565.00
Operating Profit (PBDIT) excl Other Income
2,536.00
1,901.00
1,990.00
1,649.00
Other Income
280.00
128.00
196.00
170.00
Operating Profit (PBDIT)
2,817.00
2,030.00
2,186.00
1,820.00
Interest
35.00
45.00
59.00
21.00
Profit before Depriciation and Tax
2,782.00
1,984.00
2,126.00
1,798.00
Depreciation
398.00
325.00
166.00
118.00
Profit Before Taxation & Exceptional Items
2,384.00
1,658.00
1,960.00
1,679.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
2,399.00
1,671.00
1,974.00
1,691.00
Provision for Tax
457.00
361.00
521.00
398.00
Profit After Tax
1,926.00
1,297.00
1,438.00
1,281.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
8,012.00
6,735.00
5,303.00
4,065.00
Profit Available for appropriations
9,925.00
8,017.00
6,736.00
5,330.00
Appropriations
9,925.00
8,017.00
6,736.00
5,330.00
Equity Dividend (%)
0.00%
0.00%
0.00%
755.00%
Earnings Per Share
47.75
32.00
35.78
31.59
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 18.12% vs 12.44% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 33.37% vs -4.45% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -23.42% vs -23.48% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 48.51% vs -9.82% in Mar 2023

Compare Profit and Loss Results of Mankind Pharma
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
10,334.00
10,727.00
-393.00
-3.66%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
10,334.00
10,727.00
-393.00
-3.66%
Expenditure (Ex Depriciation)
Stock Adjustments
-94.00
-155.00
61.00
39.35%
Raw Materials Consumed
3,263.00
2,841.00
422.00
14.85%
Power & Fuel Cost
129.00
145.00
-16.00
-11.03%
Employee Cost
2,274.00
1,984.00
290.00
14.62%
Operating Expenses
210.00
197.00
13.00
6.60%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
928.00
1,129.00
-201.00
-17.80%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
134.00
672.00
-538.00
-80.06%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
7,798.00
7,360.00
438.00
5.95%
Operating Profit (PBDIT) excl Other Income
2,536.00
3,367.00
-831.00
-24.68%
Other Income
280.00
57.00
223.00
391.23%
Operating Profit (PBDIT)
2,817.00
3,425.00
-608.00
-17.75%
Interest
35.00
353.00
-318.00
-90.08%
Profit before Depriciation and Tax
2,782.00
3,072.00
-290.00
-9.44%
Depreciation
398.00
808.00
-410.00
-50.74%
Profit Before Taxation & Exceptional Items
2,384.00
2,263.00
121.00
5.35%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,399.00
2,352.00
47.00
2.00%
Provision for Tax
457.00
695.00
-238.00
-34.24%
Profit After Tax
1,926.00
1,656.00
270.00
16.30%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
8,012.00
3,303.00
4,709.00
142.57%
Profit Available for appropriations
9,925.00
4,959.00
4,966.00
100.14%
Appropriations
9,925.00
4,959.00
4,966.00
100.14%
Equity Dividend (%)
0%
560%
-560.00
Earnings Per Share
47.75
48.94
-1.19
-2.43%
Profit And Loss - Net Sales
Net Sales 10,334.77 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 18.12% vs 12.44% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,536.59 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 33.37% vs -4.45% in Mar 2023

Profit And Loss - Interest
Interest 35.05 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -23.42% vs -23.48% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 1,926.56 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 48.51% vs -9.82% in Mar 2023